@kristinrojasmd I’ve been using the term “estrogen blockers” since 2011. You’re right, it’s easier to grasp the concept. I wonder if it has been studied: whether one term or the other leads to more uptake, openness to take.
A recent study led by our Dr. Henry Kuerer found select patients with early-stage breast cancer may be able to skip surgery: https://t.co/KTT2qRN3un
Meet him at the MD Anderson booth tomorrow, Dec. 9 from 11:00 a.m.-12:00 p.m. @HenryKuerer#SABCS22#EndCancer
Our leading #breastcancer research scientist, Dr. Steffi Oesterreich (@oesterreichs) presents two compelling studies designed to improve patient care & understanding of disease progression.
Friday Dec. 9 | Hall 1 | 7-8:15 am CT | P6-05-10
& P6-14-02 @MageeWomens@PittHealthSci
Thanks to all who participated and came to learn or support! Happy for the @SocSurgOnc Fellows & Young Attendings Subcommitee to lead this effort to connect interested trainees and PDs to learn about surgical oncology/breast careers #SSO_FYAS#ACSCC22
Check out our "Steel City Surgeons Podcast" interviewing faculty members and residents in the Department of Surgery, focusing on diversity and inclusion. Starting off with Dr. Sally Carty!! @UPMC_GME_DEI@PittEndoSurg@PittSurgery@AmCollSurgeons
https://t.co/ttXBmnbQaa
Great work by the Diversity and Inclusion team! Tune in to #SteelCitySurgeons podcast discussing Dr. Sally Carty's experience in the surgical field and how she served as a force for gender equity in the field.
So proud of what you are accomplishing @GordanaRasic!!! I cannot wait to see how you will continue to make waves in this space. Very excited to bear witness to the positive changes you will bring with your ideas and energy.